WebMD and Scripps Translational Science Institute (STSI) today announced a new investigative study designed to improve researchers’ and health care professionals’ understanding of what contributes to healthy pregnancies and positive pregnancy outcomes. The Healthy Pregnancy Study will use WebMD’s newly redesigned and enhanced Pregnancy app for iPhone. Incorporation of the Apple ResearchKit software framework will enable survey participants to eConsent, easily and anonymously answer questions, and share connected device data about their pregnancies with researchers for analysis.
“Pregnant women are one of the least studied populations in medical research,” said Dr. Eric Topol, director of STSI and editor-in-chief of Medscape. “The results of our Healthy Pregnancy Study -- on the foundation of an exceptionally popular smartphone app -- will ultimately provide expectant mothers, researchers, and health care professionals with new medical insights to avoid complications during pregnancy.”
To view the multimedia release go to:
https://www.multivu.com/players/English/7579757-webmd-stsi-healthy-pregnancy-study-app/
Blood cancers are the third leading cause of cancer deaths in the U.S. However, many Americans are unaware of the impact of these cancers, including leukemia, lymphoma and myeloma, which affect the bone marrow, the blood cells, the lymph nodes and other parts of the lymphatic system.
A new survey commissioned by The Leukemia & Lymphoma Society (LLS) reveals more than four in five adults (82%) are surprised that blood cancers are the third leading cancer killer of Americans. Further, nearly four in five adults (78%) are surprised that acute lymphocytic leukemia (ALL) is the most common cancer in children and young adults under age 20.
To view the multimedia release go to:
https://www.multivu.com/players/English/8128551-lls-blood-cancer-awareness-month/
The CDC Foundation, actor Idris Elba and a global team of African soccer stars, international health and aid organizations today announced the launch of Africa United, a global health communications campaign aimed at preventing the spread of Ebola in West Africa. Africa United will leverage campaign partners and celebrities to provide critical education and resources for the people of West Africa.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7390651-cdc-foundation-we-are-africa-united-ebola-health-workers/
Boston Scientific (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval for the SYNERGY™ Bioabsorbable Polymer Drug-Eluting Stent System (BP-DES) for the treatment of coronary artery disease.
With this FDA approval, Boston Scientific will commence commercialization of the first and only BP-DES in the U.S. Notably, both the drug coating and the polymer – which modulates drug release – are fully absorbed shortly after drug elution is complete at three months.
The SYNERGY Stent provides synchronized drug and polymer absorption. It is designed to enable more rapid and complete arterial healing, and to thereby reduce the risk of complications associated with long-term polymer exposure compared to currently-used drug-eluting stents (DES) with permanent polymers.
To view the multimedia release go to:
http://www.multivu.com/players/English/7223456-boston-scientific-fda-approval-synergy/
Federally funded research continues to spur progress against cancer; however, accelerating the pace of progress will require robust, sustained, and predictable annual funding increases for the National Institutes of Health (NIH), the National Cancer Institute (NCI), and the Food and Drug Administration (FDA). Additionally, strong financial support for the National Cancer Moonshot Initiative is required, according to the sixth annual American Association for Cancer Research (AACR) Cancer Progress Report, released today.
One of the most exciting new approaches to cancer treatment is cancer immunotherapy. As detailed in the report, the utility of immunotherapy is expanding rapidly. For example, on Aug. 1, 2015, one class of immunotherapeutics, checkpoint inhibitors, was initially approved for just two types of cancer—melanoma and lung cancer. As of Sept. 1, 2016, checkpoint inhibitors have been approved for treating six types of cancer—bladder cancer, head and neck cancer, Hodgkin lymphoma, kidney cancer, lung cancer, and melanoma.
To view the multimedia release go to:
http://www.multivu.com/players/English/7911951-aacr-2016-cancer-progress-report/
USANA Health Sciences is pleased to announce an innovative technological advancement: its U.S. patent-pending USANA InCelligence Technology™. This exclusive cell-signaling technology—now found in various USANA® products—is designed to help your body’s cells renew and protect themselves in unique and powerful ways, representing a monumental leap forward in cellular nutrition and overall wellness.*
“USANA continues to build a reputation as an innovator in the science of cellular health and nutritional supplementation,” says USANA Founder Dr. Myron Wentz. “With USANA’s InCelligence Technology, we are ensuring that our company remains on the cutting-edge of nutritional supplementation.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7736551-usana-incelligence-technology/
The Ad Council, the largest producer of public service campaigns in the U.S., in partnership with Viacom, home to premier global brands in media and entertainment, and non-profit leader Facing Addiction today launched the PSA campaign “LISTEN” to ignite a national conversation about drug and alcohol addiction as a public health epidemic, and empower those impacted by substance use disorders.
While past PSA campaigns have traditionally focused on the perspective of those at risk, urging them to eliminate all substance use, “LISTEN” addresses the support system of people who are also affected by this crisis. Using powerful stories that portray the modern faces of addiction and recovery, the campaign looks to remove the stigma attached to substance misuse through the act of informed, compassionate listening. The campaign’s website, heretolisten.com, and Facing Addiction's Resource Hub provides important tools and information to help people start a productive conversation with their friends and loved ones and to support the more than 45 million Americans directly impacted by addiction.
To view the multimedia release go to:
http://www.multivu.com/players/English/8029751-ad-council-listen-psa-addiction-drug-alcohol-substance-abuse/
Eli Lilly and Company (NYSE: LLY) will commemorate its 140th anniversary today with activities at Lilly locations worldwide, including a ceremony to unveil a statue dedicated to founder Colonel Eli Lilly at global headquarters in Indianapolis.
Over 14 decades, the organization has contributed more than 100 medicines and significant medical advances, such as the first commercially available insulin, manufacturing and global distribution of the Salk polio vaccine and mental health breakthroughs such as anti-depressant Prozac® (fluoxetine). Today Lilly continues to progress its most robust pipeline in history with dozens of potential new medicines in mid- to late-stage development for cancer, diabetes, autoimmune disease, pain and Alzheimer’s disease.
“As Lilly celebrates 140 years, we’re keeping the vision of our founder alive – from our dedication in the lab to our impact in the community,” said John C. Lechleiter, Ph.D., Lilly chairman, president and chief executive officer, who began his career at Lilly as a chemist in 1979. “Colonel Eli Lilly started this company to put science to work fighting disease and encouraged his successors to ‘take what you find here and make it better and better.’ That vision pushes us daily to honor Colonel Lilly’s legacy and continue in our quest to discover new medicines to help make life better.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7809951-eli-lilly-and-company-140th-anniversary/
May is Mental Health Awareness Month. Nine out of ten times when someone dies by suicide, they have a diagnosable mental health condition at the time of their death. However, mental health conditions are treatable, and most people who attempt suicide go on to live healthy productive lives.
Join the American Foundation for Suicide Prevention, the largest suicide prevention organization in the United States, in celebrating Mental Health Awareness Month. By drawing attention to the importance of mental health we hope to save lives and bring hope to those affected by suicide. Taking care of your mental health is the smart thing to do.
“Mental health is as important as physical health. It impacts the way we perceive, think, feel and behave in our daily lives,” said Dr. Christine Moutier, the chief medical officer of the American Foundation for Suicide Prevention. “To help us prevent suicide, there is a role for everyone, in every community. Don’t be afraid to have a caring conversation with someone if you notice troubling changes in their behavior. This conversation just might save their life.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7824851-afsp-suicide-mental-health-awareness-month/
nanobébé, a brand dedicated to revolutionizing the infant feeding industry, today announced the launch of its much-anticipated sleek and modern ecosystem of health-focused feeding essentials for today’s 21st century parents, poised to be hot baby registry items this year. Breastfeeding moms can rejoice in the company’s flagship Breastmilk Bottle, the first and only baby bottle designed specifically to preserve essential breast milk nutrients. From pumping, storing, warming to feeding, the award-winning nanobébé Breastmilk Bottle protects the breast milk and preserves its nutritional value.
“When moms warm breast milk in the traditional way, there is a good chance that they are unknowingly damaging the nutritional and immunity-boosting properties of the milk. Additionally, the milk is likely heated unevenly, causing hot spots, which can harm the baby,” said Rallie McAllister, MD, MPH, nanobébé SpokesDoctor, family physician and coauthor of The Mommy MD Guide to Your Baby’s First Year. “nanobébé’s bottles are biomedically engineered with a concave shape that spreads the breast milk into a thin layer and allows it to warm at safe temperatures, protecting nutrients from damage and preventing hot spots.” The nanobébé Breastmilk Bottle warms stored breast milk quickly, twice as fast as standard bottles.
To view the multimedia release go to:
https://www.multivu.com/players/English/8260351-nanobebe-infant-breastfeeding-line/
The Wingman, a new condom from the Netherlands, has won the iF Gold Award 2014. A price which is considered the highest international distinction, “the Oscar for product design.” Newcomer Wingman now joins a line of renowned winners such as Apple, Nokia, Philips and Porsche.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/65018-condom-with-wings-wins-oscar-product-design
